Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion
about
Ceramide: a common pathway for atherosclerosis?The adipokine/ceramide axis: key aspects of insulin sensitizationExogenous and endogenous ceramides elicit volume-sensitive chloride current in ventricular myocytes.Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.Sphingolipids in obesity, type 2 diabetes, and metabolic disease.Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death.Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice.Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.Enhancing Cardiac Triacylglycerol Metabolism Improves Recovery From Ischemic Stress.Recent advances in the immunobiology of ceramide.Secreted tyrosine sulfated-eIF5A mediates oxidative stress-induced apoptosis.Diabetic cardiomyopathy: where are we 40 years later?Effects of Yiqi Tongyang on HCN4 Protein Phosphorylation in Damaged Rabbit Sinoatrial Node Cells.Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.Sphingolipid therapy in myocardial ischemia-reperfusion injury.Lipotoxic heart disease in obese rats: implications for human obesity.Neuroendocrine and cardiac metabolic dysfunction and NLRP3 inflammasome activation in adipose tissue and pancreas following chronic spinal cord injury in the mouse.Suppression of Acid Sphingomyelinase Protects the Retina from Ischemic Injury.Ceramide and mitochondria in ischemia/reperfusion.Genetic determinants of circulating sphingolipid concentrations in European populations.Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide.Autoproteolytic cleavage and activation of human acid ceramidase.Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation.Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.Signal transduction of stress via ceramide.Apoptosis after reperfused myocardial infarction: Role of angiotensin II.The challenge to verify ceramide's role of apoptosis induction in human cardiomyocytes--a pilot study.Effect of Gegen Qinlian Decoction on Cardiac Gene Expression in Diabetic Mice.MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review.Ceramide and Ischemia/Reperfusion Injury.Muscle cells become necrotic rather than apoptotic during reperfusion of ischaemic skeletal muscle.Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.
P2860
Q24630011-C1D9822E-EF32-4674-B4EB-A7004AB950E5Q27025041-764361EC-8520-4C1B-B510-E6543E01BAD7Q30493572-4DA186F1-0431-4C95-A6DF-5459EBBBD435Q33792389-998B3D83-5EC4-4A41-B946-3111A8B98EC3Q33880588-C81455DF-B064-48AC-95AC-DD6E9A048E6AQ33986280-B70700E6-9B89-4E03-A8F0-43CE942A7256Q33993301-B51FBC93-A8C1-4A56-9158-040016A30DA9Q35048357-F632BA2B-5B02-4E2E-A641-7889BA84D5F2Q35395763-69F5BAAB-B278-4C07-9F18-CFAC58C6D44CQ35881763-D54FE04F-AB05-46B0-B84B-35C45C1C4135Q35916828-8E8D1F02-5D3B-4031-90A5-2DF1C87EFA87Q36035366-ED22F952-5CB2-4585-BF60-C74F7570985AQ36433600-C6953BD0-EF03-44C3-9924-7C7CC6E3DDD5Q36741415-F1FABF45-A12A-4E03-BC5F-6B5D31CC3AA3Q36861002-1B3497E1-9560-474A-A08F-402BE1879092Q36885497-B95E4E98-AD5D-40CF-8C57-61FA4FED2999Q36967504-805DC7F4-1801-4930-A2C7-31F0A295E035Q37117677-40EEE014-F47D-4379-8937-FD4D4AAD2344Q37212058-9B1FBCFA-2202-4838-AEDC-17802D92FE4AQ37242139-9FB01D3A-9518-4107-99F2-45C2298DB94BQ37344754-99BFAF33-5076-4751-90BF-00C1C65E3312Q37350436-1BCB4267-138E-400F-9DEB-6FBB28203D88Q37463334-ACE80989-FEE8-47E5-9EE4-F81B79A4614EQ39262060-DEEF747D-DD03-42E8-BF07-D75B7FEB0E33Q40774230-1A194113-76AA-406F-8E7A-CBDF751F07B5Q41829826-EF54DC99-DE68-4B37-8D93-723E4D9D9D1BQ41841345-0A8B2BEE-36AB-4498-84EC-CBE4C97E8DECQ42078470-CF5EE276-7D62-41D2-B74B-60053D2D8251Q42213402-607A6F51-51C8-4A7E-9F82-09E296389091Q48146214-CD0FAC70-930C-4A3E-8E85-0C38DEEBAB99Q50026688-F1278504-C090-4051-AE02-4F5C3A4F5BD9Q52333935-7D7CBC40-596F-4E54-878A-CB4381685D28Q52536230-106D3B02-F153-42FD-A3FB-5E1605A1A257Q55278796-4E28046E-225F-4370-A368-02D2FB465D86
P2860
Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Ceramide is involved in trigge ...... ed by ischemia and reperfusion
@ast
Ceramide is involved in trigge ...... ed by ischemia and reperfusion
@en
type
label
Ceramide is involved in trigge ...... ed by ischemia and reperfusion
@ast
Ceramide is involved in trigge ...... ed by ischemia and reperfusion
@en
prefLabel
Ceramide is involved in trigge ...... ed by ischemia and reperfusion
@ast
Ceramide is involved in trigge ...... ed by ischemia and reperfusion
@en
P2093
P2860
P1476
Ceramide is involved in trigge ...... ed by ischemia and reperfusion
@en
P2093
Bielawska AE
Melkonyan HS
Shapiro JP
Umansky SR
P2860
P304
P407
P577
1997-11-01T00:00:00Z